High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This trial studies how well high dose vitamin A compound works in treating participants with
non-small cell lung cancer that can be removed by surgery. Vitamin A compound may increase
the number of germinal centers (immune centers that make antibodies mature) in tumor and
lymph tissues which may be beneficial to patients with cancer.